SCHEMBL13865112

SCHEMBL13865112

COc1ccc(CC(=O)Nc2cc(-c3ccncc3)n[nH]2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.61
ALDH1A1 P00352 3/20 0.61
ROCK1 Q13464 2/20 0.61
MEN1 O00255 1/20 0.61
KMT2A Q03164 1/20 0.61
NOD2 Q9HC29 1/20 0.54
MAPK8 P45983 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.51
WNT3A P56704 3/20 0.51
CYP3A4 P08684 2/20 0.51
ADORA3 P0DMS8 1/20 0.50
ADORA2A P29274 1/20 0.50
GSK3A P49840 1/20 0.50
GSK3B P49841 1/20 0.50
DYRK1A Q13627 1/20 0.50
APP P05067 1/20 0.50
PRKACA P17612 1/20 0.49
LMNA P02545 2/20 0.49
MAPK10 P53779 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13376861 0.88 ROCK1 (0.65) MAPTALDH1A1ROCK1CYP3A4PRKACA
SCHEMBL13865104 0.87 ALPL (0.54) MAPTALDH1A1ROCK1MEN1KMT2A
SCHEMBL13865106 0.86 NPC1 (0.59) MAPTALDH1A1ROCK1KMT2ASMN1; SMN2
SCHEMBL13376907 0.85 GLS (0.48) MAPTALDH1A1ROCK1MEN1KMT2A
SCHEMBL13376935 0.85 ROCK1 (0.59) ROCK1MEN1KMT2AWNT3AGSK3B
SCHEMBL13376879 0.84 ROCK1 (0.57) MAPTALDH1A1ROCK1WNT3APRKACA
SCHEMBL13865111 0.82 NPY5R (0.53) ROCK1MEN1KMT2AMAPK8WNT3A
SCHEMBL6386962 0.81 CDK2 (0.51) MAPTALDH1A1ROCK1MEN1KMT2A
SCHEMBL6386968 0.81 CDK2 (0.51) MAPTALDH1A1ROCK1MEN1KMT2A
SCHEMBL7922566 0.81 MAPT (0.59) MAPTALDH1A1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7531556-B2 Compositions useful as inhibitors of rock and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-05-12 US disclosed
US-7531556-B2 Compositions useful as inhibitors of rock and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-05-12 US disclosed